Statins and infrainguinal vascular bypass procedures.
Kosmas I Paraskevas1, Athanasios D Giannoukas, Dimitri P Mikhailidis
1Department of Vascular Surgery, Red Cross Hospital, Athens, Greece.
Current Vascular Pharmacology
|February 9, 2013
Summary
Statins significantly benefit patients with peripheral arterial disease by reducing mortality and improving bypass graft outcomes. These cholesterol-lowering drugs enhance graft patency and decrease restenosis and amputation risks.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Peripheral arterial disease (PAD) poses significant risks for mortality and morbidity.
- Statins are widely used for cardiovascular risk reduction.
Purpose of the Study:
- To review the beneficial effects of statins in patients with PAD.
- To explore the role of statins in infrainguinal bypass graft procedures.
Main Methods:
- Literature review of studies on statin use in PAD patients.
- Analysis of data on perioperative and long-term outcomes.
- Examination of graft patency, restenosis, and amputation rates.
Main Results:
- Statins improve perioperative and long-term mortality and morbidity in PAD patients.
- Evidence suggests statins enhance infrainguinal bypass graft patency.
- Statins are associated with reduced graft restenosis and amputation rates.
Conclusions:
- Statins offer significant benefits for PAD patients, regardless of treatment strategy.
- Statin therapy is crucial for improving outcomes in patients undergoing infrainguinal bypass grafting.
- Further research into the pathomechanisms of statin benefits in PAD is warranted.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...